PACs from litchi have been found to enhance the infiltration of CD8+ cytotoxic T lymphocytes and decrease the quantity of macrophages, thereby modulating the tumor microenvironment and potentially augmenting the effectiveness of immunotherapies against colon cancer (67). Here, CD8A is linked to malignant colon neoplasm.